BEAM logo

Beam Therapeutics Inc. (BEAM) Free Cash Flow

Annual FCF:

-$356.19M-$173.26M(-94.72%)
December 31, 2024

Summary

  • As of today, BEAM annual free cash flow is -$356.19 million, with the most recent change of -$173.26 million (-94.72%) on December 31, 2024.
  • During the last 3 years, BEAM annual free cash flow has fallen by -$243.11 million (-214.99%).
  • BEAM annual free cash flow is now -11566.95% below its all-time high of -$3.05 million, reached on December 31, 2017.

Performance

BEAM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

Quarterly FCF:

-$79.59M+$27.36M(+25.59%)
June 30, 2025

Summary

  • As of today, BEAM quarterly free cash flow is -$79.59 million, with the most recent change of +$27.36 million (+25.59%) on June 30, 2025.
  • Over the past year, BEAM quarterly free cash flow has increased by +$5.38 million (+6.34%).
  • BEAM quarterly free cash flow is now -137.68% below its all-time high of $211.23 million, reached on March 31, 2022.

Performance

BEAM Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

TTM FCF:

-$355.57M+$5.38M(+1.49%)
June 30, 2025

Summary

  • As of today, BEAM TTM free cash flow is -$355.57 million, with the most recent change of +$5.38 million (+1.49%) on June 30, 2025.
  • Over the past year, BEAM TTM free cash flow has dropped by -$202.17 million (-131.79%).
  • BEAM TTM free cash flow is now -339.91% below its all-time high of $148.21 million, reached on March 31, 2022.

Performance

BEAM TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

BEAM Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-94.7%+6.3%-131.8%
3Y3 Years-215.0%-7.7%-389.1%
5Y5 Years-321.4%-215.8%-256.9%

BEAM Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-1248.0%at low-160.5%+31.3%-1000.4%+9.3%
5Y5-Year-1248.0%at low-137.7%+31.3%-339.9%+9.3%
All-TimeAll-Time>-9999.0%at low-137.7%+31.3%-339.9%+9.3%

BEAM Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$79.59M(+25.6%)
-$355.57M(+1.5%)
Mar 2025
-
-$106.95M(-34.8%)
-$360.96M(-1.3%)
Dec 2024
-$356.19M(-94.7%)
-$79.33M(+11.6%)
-$356.19M(-145.0%)
Sep 2024
-
-$89.70M(-5.6%)
-$145.37M(+5.2%)
Jun 2024
-
-$84.97M(+16.8%)
-$153.40M(+9.4%)
Mar 2024
-
-$102.19M(-177.7%)
-$169.28M(+7.5%)
Dec 2023
-$182.93M(-592.3%)
$131.48M(+234.5%)
-$182.93M(+53.3%)
Sep 2023
-
-$97.73M(+3.1%)
-$391.86M(-3.0%)
Jun 2023
-
-$100.85M(+12.9%)
-$380.41M(-7.6%)
Mar 2023
-
-$115.83M(-49.6%)
-$353.49M(-1237.7%)
Dec 2022
-$26.42M(+76.6%)
-$77.45M(+10.2%)
-$26.42M(-166.9%)
Sep 2022
-
-$86.28M(-16.7%)
$39.49M(-67.9%)
Jun 2022
-
-$73.92M(-135.0%)
$123.00M(-17.0%)
Mar 2022
-
$211.23M(+1930.6%)
$148.21M(+231.1%)
DateAnnualQuarterlyTTM
Dec 2021
-$113.08M(-0.9%)
-$11.54M(-316.1%)
-$113.08M(+15.6%)
Sep 2021
-
-$2.77M(+94.3%)
-$133.96M(+13.7%)
Jun 2021
-
-$48.71M(+2.7%)
-$155.22M(-17.8%)
Mar 2021
-
-$50.06M(-54.4%)
-$131.72M(-17.5%)
Dec 2020
-$112.10M(-32.6%)
-$32.42M(-34.9%)
-$112.10M(-12.5%)
Sep 2020
-
-$24.03M(+4.7%)
-$99.64M(-6.0%)
Jun 2020
-
-$25.20M(+17.2%)
-$94.01M(-8.4%)
Mar 2020
-
-$30.44M(-52.5%)
-$86.75M(-2.6%)
Dec 2019
-$84.52M(-152.9%)
-$19.96M(-8.4%)
-$84.52M(-7.3%)
Sep 2019
-
-$18.41M(-2.6%)
-$78.75M(-30.5%)
Jun 2019
-
-$17.94M(+36.4%)
-$60.34M(-42.3%)
Mar 2019
-
-$28.21M(-98.8%)
-$42.40M(-198.8%)
Dec 2018
-$33.42M(-994.7%)
-$14.19M
-$14.19M
Dec 2017
-$3.05M
-
-

FAQ

  • What is Beam Therapeutics Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. annual free cash flow year-on-year change?
  • What is Beam Therapeutics Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. quarterly free cash flow year-on-year change?
  • What is Beam Therapeutics Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Beam Therapeutics Inc.?
  • What is Beam Therapeutics Inc. TTM free cash flow year-on-year change?

What is Beam Therapeutics Inc. annual free cash flow?

The current annual free cash flow of BEAM is -$356.19M

What is the all-time high annual free cash flow for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high annual free cash flow is -$3.05M

What is Beam Therapeutics Inc. annual free cash flow year-on-year change?

Over the past year, BEAM annual free cash flow has changed by -$173.26M (-94.72%)

What is Beam Therapeutics Inc. quarterly free cash flow?

The current quarterly free cash flow of BEAM is -$79.59M

What is the all-time high quarterly free cash flow for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high quarterly free cash flow is $211.23M

What is Beam Therapeutics Inc. quarterly free cash flow year-on-year change?

Over the past year, BEAM quarterly free cash flow has changed by +$5.38M (+6.34%)

What is Beam Therapeutics Inc. TTM free cash flow?

The current TTM free cash flow of BEAM is -$355.57M

What is the all-time high TTM free cash flow for Beam Therapeutics Inc.?

Beam Therapeutics Inc. all-time high TTM free cash flow is $148.21M

What is Beam Therapeutics Inc. TTM free cash flow year-on-year change?

Over the past year, BEAM TTM free cash flow has changed by -$202.17M (-131.79%)
On this page